Scientists use suction blisters to peek inside skin inflammation
NCT ID NCT05535738
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to understand how inflammation works in the skin and how certain anti-inflammatory drugs (biologics) affect it. Researchers will create small suction blisters on the skin of healthy volunteers and people with skin conditions, then analyze the fluid and cells. The goal is to gather detailed information about the immune response, not to treat any disease directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dupilumab, Adalimumab, Ustekinumab, Guselkumab, Canakinumab, Sarilumab, and squaric acid dibutyl ester
What this could lead to
If successful, this could help researchers understand how different anti-inflammatory drugs work in the skin, potentially guiding better treatments for skin conditions.
What could go wrong
This is an early-stage exploratory study with only 45 participants. It is designed to gather knowledge, not to test a treatment for a specific disease, so results may not directly lead to new therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Massachusetts Chan Medical School
Worcester, Massachusetts, 01605, United States